Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.004 Å; disorder in main residue; R factor = 0.062; wR factor = 0.158; data-to-parameter ratio = 13.1.
In the crystal structure of the title compound, C 30 H 24 N 4 O 2 S, the dihydroquinoxaline fused-ring system is disordered over three orientations in a 0.358 (2):0.318 (3):0.324 (3) ratio; the mean planes of the non-H atoms of the disorder components are aligned at 4.0 (3), 11.8 (4) and 41.7 (2) with respect to the pyrazole ring. The rings of the phenyl and tolyl substituents are aligned at 64.0 (1) and 43.7 (1) with respect to the pyrazole ring. Weak intermolecular C-HÁ Á ÁO hydrogen bonding links the molecules, forming supramolecular chains running along the a axis.
Related literature
For background to the biological properties of aryl-substituted pyrazoles, see: Abdel-Aziz et al. (2010) . Table 1 Hydrogen-bond geometry (Å , ).
Experimental
Symmetry code: (i) x À 1; y; z.
Data collection: CrysAlis PRO (Agilent, 2010); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: X-SEED (Barbour, 2001); software used to prepare material for publication: publCIF (Westrip, 2010). Fig. 1 . Thermal ellipsoid plot (Barbour, 2001) of C 30 H 24 N 4 O 2 S at the 70% probability level; hydrogen atoms are drawn as spheres of arbitrary radius. The disorder is not shown. Geometric parameters (Å, °) S1-O1 1.432 (2) C1"-C9 1.512 (8) S1-O2 1.436 (2) C2"-H2"A 0.9900 S1-C10 1.754 (2) C2"-H2"B 0.9900 S1-C12 1.769 (2) C3"-C4" 1.3900 N1-C1 1.322 (9) C3"-C8" 1.3900 N1-C8 1.375 (9) C4"-C5" 1.3900 N2-C2 1.370 (9) C4"-H4" 0.9500 N2-C3 1.408 (7) C5"-C6" 1.3900 N2-N2 i 1.856 (16) C5"-H5" 0.9500 N2-H2 0.8800 C6"-C7" 1.3900 N1'-C1' 1.358 (10) C6"-H6" 0.9500 N1'-C8' 1.379 (9) C7"-C8" 1.3900 N2'-C2' 1.385 (9) C7"-H7" 0.9500 N2'-C3' 1.3900 C30-H30B 0.9800 C7'-H7' 0.9500 C30-H30C 0.9800 C1"-C2" 1.470 (9) O1-S1-O2 116.63 (13) C8"-C3"-N2" 122.5 (6) O1-S1-C10 111.78 (12) C5"-C4"-C3" 120.0 O2-S1-C10 106.57 (11) C5"-C4"-H4" 120.0 O1-S1-C12 108.98 (12) C3"-C4"-H4" 120.0 O2-S1-C12 107.84 (11) C4"-C5"-C6" 120.0 C10-S1-C12 104.29 (12) C4"-C5"-H5" 120.0 C1-N1-C8 112.2 (10) C6"-C5"-H5" 120.0 C2-N2-C3 108.9 (9) C7"-C6"-C5" 120.0 C2-N2-N2 i 98.0 (8) C7"-C6"-H6" 120.0 C3-N2-N2 i 135.4 (9) C5"-C6"-H6" 120.0 C2-N2-H2 125.5 C8"-C7"-C6" 120.0 C3-N2-H2 125.5 C8"-C7"-H7" 120.0 C1'-N1'-C8' 127.4 (13) C6"-C7"-H7" 120.0 C2'-N2'-C3' 123.8 (10) N1"-C8"-C7" 117.5 (6) C2'-N2'-H2' 118.1 N1"-C8"-C3" 122.3 (6) C3'-N2'-H2' 118.1 C7"-C8"-C3" 120.0 C1"-N1"-C8" 117.2 (7) N3-C9-C10 110.6 (2) C2"-N2"-C3" 115.8 (7) N3-C9-C1 113.7 (6) C2"-N2"-H2" 122.1 C10-C9-C1 134.2 (6) supplementary materials sup-11 C2-C1-C9-C1" −117 (2) C27-C28-C29-C24 0.1 (4) N1'-C1'-C9-N3 −161.6 (12) Symmetry codes: (i) −x+1, −y+1, −z+2. 
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